Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
07:08pm, Wednesday, 18'th Jun 2025
Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country'
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
10:47am, Wednesday, 18'th Jun 2025
Scholar Rock SRRK revealed results on Wednesday from the Phase 2 EMBRAZE proof-of-concept trial assessing apitegromab in combination with tirzepatide to preserve lean mass during tirzepatide-induced
Gene-Editing Stocks Gain on LLY-VERV Deal Announcement
10:35am, Wednesday, 18'th Jun 2025
LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
09:53am, Wednesday, 18'th Jun 2025
Eli Lilly (LLY -0.41%) has been one of the hottest healthcare stocks to own in recent years, thanks in large part to the success of its incredibly successful GLP-1 agonist drugs, which help patients w
Beyond Obesity: Eli Lilly's Genetic Medicine Bet On Verve Therapeutics
08:55am, Wednesday, 18'th Jun 2025
Eli Lilly's $1.3 billion acquisition of Verve Therapeutics represents a strategic move into cardiovascular genetic medicine. The pharmaceutical behemoth paid a substantial premium of approximately 113
5 Blue-Chip Giants That Have Paid Dividends for 100 Years and Longer
04:18pm, Tuesday, 17'th Jun 2025
There are over 12,000 publicly traded stocks in the United States; not even the most intelligent investors with the best tools can find them all immediately.
Lilly to buy gene-editing partner Verve for $1.3 billion
12:57pm, Tuesday, 17'th Jun 2025
CNBC's Angelica Peebles reports on the latest news surrounding Eli Lilly.
Eli Lilly is making it cheaper and easier to buy high doses of blockbuster weight-loss drug Zepbound
11:39am, Tuesday, 17'th Jun 2025
Eli Lilly announced on Monday it will soon make the two highest doses of its popular weight-loss drug Zepbound available for self-paying customers on its website.
JBLU Cutting Back Flights, Solar Stocks Sell, LLY Bid for VERV
10:30am, Tuesday, 17'th Jun 2025
Breaking news hits Morning Trade Live with JetBlue (JBLU) cutting back flights after it reported weaker travel demand. Diane King Hall talks about the report and shares how it differs from its airline
Eli Lilly: The Buy Case Gets Stronger (Rating Upgrade)
08:46am, Tuesday, 17'th Jun 2025
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition costs. Even though oncology, the segment in which the acquisition was made, has
This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly
08:13am, Tuesday, 17'th Jun 2025
Verve Therapeutics' stock rallies by a record 80% on Eli Lilly's premium purchase price for the drug-development company.
Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion
07:55am, Tuesday, 17'th Jun 2025
Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a potential treatment for cardiovascular disease to its portfolio.
Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say
06:54am, Tuesday, 17'th Jun 2025
Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday.
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
06:45am, Tuesday, 17'th Jun 2025
Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease Lilly's established capabilities in cardi
Eli Lilly Close to $1.3 Billion Bid for Biotech, Says Report. Verve Therapeutics Stock Soars 80%.
05:33am, Tuesday, 17'th Jun 2025
A report said the two pharmaceutical companies are in advance talks.
